Survival of VRd vs. Rd within each frailty category. Kaplan-Meier analyses of patients who were (A) moderate-severely frail, (B) mildly frail, and (C) nonfrail with newly diagnosed MM, evaluating differences in survival between those initially treated with VRd (orange) and those initially treated with Rd (blue), after matching for stage and PS within each frailty category.